News
Medindia on MSN1d
Next-Gen Nasal Spray Gene Therapy Targets Lung Diseases and COVID-19Scientists engineered a way to deliver genes directly to lung and airway cells using a nasal spray * AAV.CCP.16 -// a viral ...
Clinical Trials Arena on MSN1d
Patient dies in Rocket’s Phase II Danon disease gene therapy trialA patient has died in a pivotal Phase II trial of Rocket Pharmaceuticals’ gene therapy for Danon disease after suffering a ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...
For gene therapy to work well, therapeutic molecules need to be efficiently delivered to the correct locations in the body -- a job commonly given to adeno-associated viruses (AAV). To improve the AAV ...
Qure divested for $25M, advanced AMT-130 with FDA approvals, and building infrastructure. A strong balance sheet backs ...
Researchers from The University of Osaka find that mass photometry can distinguish between full and empty rAAV particles, ...
While the medical world is melting down from the absolute apocalypse that is RFK Jr., it's good to celebrate that (at least ...
Hot on the heels of a $150 million fundraise, Atsena Therapeutics is back with early-stage data for the company’s eye disease ...
A personalized gene editing therapy was successfully used to treat an infant with CPS1 deficiency, a disease that causes ...
Ask scientists which gene-editing tool is most needed to advance gene therapy, and they'd probably describe a system that's ...
US researchers have engineered a novel gene therapy to target the airway and lungs via a nasal spray. For gene therapy to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback